Inbar Galia
SEC CIK 1878086 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | See "Remarks" | 40.3K | — | — | 4 | 2022-02-28 | 2023-03-04 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Inbar Galia made no open-market trades at TEVA in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-07 | 2023-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Inbar Galia | See "Remarks" | M - OptEx | — | +25.8K | 40.3K | +178% | — |
| D | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Inbar Galia | See "Remarks" | M - OptEx | — | +4,828 | 20.2K | +31% | — |
| D | 2022-03-08 | 2022-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Inbar Galia | See "Remarks" | M - OptEx | — | +5,710 | 15.4K | +59% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Inbar Galia | See "Remarks" | M - OptEx | — | +4,828 | 9,656 | +100% | — |
Purchase Sale Sale after option exercise All abbreviations